Recent news on Travatan

Alcon CFO sees 1 pct margin growth/yr, exceed 8-10 pct sales ...  -  May 13, 2007
Forbes,Travatan, a drug to treat glaucoma -- expected to receive regulatory clearance in Japan in the second half -- should bring about 'substantial' sales growth

Alcon’s First Quarter Sales Rise 14.3 Percent  -  Apr 25, 2007
Business Wire (press release),Sales of glaucoma products increased 16.9 percent, due to growth in sales of the TRAVATAN ® family of ophthalmic solutions and Azopt ® ophthalmic suspension

Alcon's First Quarter Sales Rise 14.3 Percent  -  Apr 25, 2007
American Digital Networks (press release),Sales of glaucoma products increased 16.9 percent, due to growth in sales of the TRAVATAN(R) family of ophthalmic solutions and Azopt(R) ophthalmic

Glaucoma Experts Determine That Reducing Intraocular Pressure ...  -  May 11, 2007
Medical News Today (press release),A retrospective analysis of the Xalatan Lumigan Travatan (XLT) study show that three prostaglandins, latanoprost, bimatoprost and travoprost reduce the

Alcon’s First Quarter Sales Rise 14.3 Percent  -  26 Apr 2007
Business Wire (press release),Sales of glaucoma products increased 16.9 percent, due to growth in sales of the TRAVATAN ® family of ophthalmic solutions and Azopt ® ophthalmic suspension

Alcon global sales up 16.1% in fourth quarter 2006  -  Feb 12, 2007
OSN SuperSite (subscription),Pharmaceutical sales grew 20.4% to $475.9 million, led by sharp increases in sales of the glaucoma medications Travatan (travoprost), Azopt (brinzolamide)

Alcon's Fourth Quarter Sales Rise 16.1 Percent  -  Feb 8, 2007
PharmaLive.com (press release),Sales of glaucoma products increased 17.1 percent to $184.6 million, led by sales of Travatan(R) ophthalmic solution and Azopt(R) ophthalmic suspension.

Alcon Q4 Profit Jumps; Sees Higher FY07 Profit  -  Feb 7, 2007
Trading Markets,Sales of glaucoma products increased 17.1% to $184.6 million, led by sales of Travatan ophthalmic solution and Azopt ophthalmic suspension, while sales of

A Victim of Myopia  -  Dec 10, 2006
Barron's (subscription)Alcon also produces Travatan, a relatively new glaucoma treatment. It has about 9% of a market in which it is the fastest-growing drug. ...

FDA Approvals: Risperdal/Risperdal M-TAB, Travatan Z, Rituxan  Oct 24, 2006
On September 21, the FDA approved travoprost 0.004% ophthalmic solution (Travatan Z, made by Alcon, Inc) for the reduction of elevated intraocular pressure (IOP ... -Medscape (subscription) Alcon’s Third Quarter Sales Rise 12.4 Percent  Oct 23, 2006
Sales of glaucoma products increased 14.6 percent to $175.7 million, led by sales of Travatan ® ophthalmic solution and Azopt ® ophthalmic suspension. ... -Business Wire (press release), Foro de Shell Security - Seguridad informática  Oct 26, 2006
...acid f small lymphocytes generally have a more indolent course com tranxene ared with those of large lymphocytes, which may have in travatan ermediate-grade or ... -Shell Security, FDA Approves Alcon's Travatan Z  Sep 22, 2006
...said Friday the Food and Drug Administration approved its Travatan Z 0.004 percent opthalmic solution for the reduction of elevated intraocular pressure. ... -Houston Chronicle

Alcon Granted FDA Approval For Travatan Solution For Treatment Of ...  Sep 21, 2006
...(ACL | charts | news | PowerRating) announced today that the US Food and Drug Administration or FDA has approved Travatan Z 0.004% for the reduction of ... -Trading Markets

Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of ...  Sep 21, 2006
21, 2006--Alcon, Inc. (NYSE:ACL) announced today that the US Food and Drug Administration (FDA) has approved TRAVATAN(R) Z (travoprost ophthalmic solution ... -Business Wire



Alcon's First Quarter Sales Rise 8.1 Percent, Net Earnings ...  Apr 25, 2006
Sales of glaucoma products increased 2.9 percent, due to growth in sales of Travatan(R) and Azopt(R) ophthalmic solutions which offset declines in older ... - PharmaLive.com





Alcon's Fourth Quarter Sales Rise 10.7 Percent  Feb 8, 2006
Sales of glaucoma products increased 19.7 percent, led by a 37.8 percent rise in sales of Travatan(R) ophthalmic solution. In ... - Finanzen.net,

(BW) Alcon's Fourth Quarter Sales Rise 10.7 Percent  Feb 8, 2006
Sales of glaucoma products increased 19.7 percent, led by a 37.8 percent rise in sales of Travatan(R) ophthalmic solution. In ... - Houston Chronicle

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional